Business Context and Reporting Period
OrthoPediatrics Corp. (KIDS) filed this Form 8-K on January 8, 2024, to announce preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2023. The filing also includes management's projection for 2024 net revenue and a business update.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing preliminary net revenue estimates, but the actual figures are not included in the provided text.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text. The document states that fourth quarter and full-year 2023 results are preliminary and subject to change upon completion of the audit process.
Guidance, Outlook, and Risks
- Guidance: Management provided a projection for 2024 net revenue, though specific targets are not listed in this text.
- Outlook: The company cautioned that actual results for 2023 and 2024 could differ materially from the preliminary estimates and forecasts.
- Risks: Investors are directed to the "Risk Factors" section of the Annual Report on Form 10-K filed on March 1, 2023, for factors that may cause actual results to differ from forward-looking statements.
- Unusual Items: The financial information is explicitly labeled as preliminary and unaudited.
Investor Verification Checklist
- Verify the specific preliminary net revenue figures for Q4 and full-year 2023 in the referenced press release (Exhibit 99.1).
- Confirm the detailed 2024 net revenue projection in the investor presentation (Exhibit 99.2).
- Review the final audited financial statements once the audit process is complete to validate the preliminary estimates.
- Consult the most recent Form 10-K for updated risk factors affecting the business outlook.